2026 Hereditary Cancer Genetics: Incorporation into Clinical Care


2026 Hereditary Cancer Genetics: Incorporation into Clinical Care Banner

Add to Calendar 2026 Hereditary Cancer Genetics: Incorporation into Clinical Care 9/17/2026 10:00:00 AM 9/18/2026 5:30:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=58981 Description: This two-day conference provides comprehensive professional training in clinical cancer genetics, hosted by Memorial Sloan Kettering Cancer Center (MSK) — one of the nation’s largest cancer genetics centers. The program features expert faculty with specialized expertise in disease-specific management and offers opportunities for participants to engage directly with speakers through panel discussions an... Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY


Date & Location
Thursday, September 17, 2026, 10:00 AM - Friday, September 18, 2026, 5:30 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties - Genetic Counseling, Genetics, Oncology and Hematology, Pediatric Oncology, Surgical Oncology

Overview

This two-day conference provides comprehensive professional training in clinical cancer genetics, hosted by Memorial Sloan Kettering Cancer Center (MSK) — one of the nation’s largest cancer genetics centers. The program features expert faculty with specialized expertise in disease-specific management and offers opportunities for participants to engage directly with speakers through panel discussions and case-based presentations. The course is designed to establish a strong foundation in cancer genetics, examine the clinical implications of genetic testing for patient care, and highlight emerging advances in cancer genomics.

Program Highlights

  • Current topics in hereditary breast, gynecologic, gastrointestinal, genitourinary, and pediatric cancers

  • Hereditary hematologic malignancies and rare cancer syndromes

  • Surveillance strategies and precision oncology

  • Advances and research in diagnosis, early detection, and cancer prevention strategies

  • Multidisciplinary panel discussions and case studies

  • Networking opportunities, including a reception on Friday evening 

Keynote Speakers

Ros Eeles

Niehaus, Southworth, Weissenbach Award Lecture
Professor Ros Eeles, FMedSci, PhD, FRCP, FRCR
The Institute of Cancer Research
London, UK

Sharon Savage

Niehaus Visiting Professor Lecture
Sharon A. Savage, MD
National Cancer Institute
National Institutes of Health
Bethesda, MD, USA

Target Audience: This course is intended for medical oncologists, genetic counselors, advanced practice providers, nurses, and other healthcare professionals seeking to incorporate cancer genetic testing into patient care. Participants may attend in person or virtually.

Syllabus: Following the conference, participants will receive access to an online syllabus with recorded presentations and downloadable slide PDFs.


Objectives
  1. Identify clinical features of hereditary cancer predisposition syndromes and facilitate interpretation of genetic test results
  2. Evaluate the recommended surveillance and risk reduction interventions for patients with hereditary cancer predisposition syndromes
  3. Enhance awareness of implications of germline genetic testing on therapeutic management of patients with cancer, including oncological and surgical interventions
  4. Apply concepts of germline variant analysis and tumor profiling to enhance clinical care of patients at risk for hereditary cancer syndromes
  5. Discuss novel advances and technologies to help improve the early detection of hereditary cancers

Registration

Registration Fees (In-Person or Virtual)

  • Physicians (MDs, PhDs, DOs): $300

  • Advanced Practice Providers and Genetic Counselors: $200

  • Residents, Fellows, Nurses, and Other Healthcare Professionals: $150

  • Industry Professionals: $525*

  • MSK Employees: Complimentary**

*An industry professional is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Please review our Registration Policy for Industry Professionals for more information.
**MSK employees receive complimentary registration for all CME programs by signing in with MSK credentials (SSO).

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Onsite Participation: Continental breakfast, lunch, and refreshment breaks will be provided for onsite participants. If you have dietary restrictions or require accommodations to attend in person, please contact [email protected] at least one week before the event. For information on travel, parking, and local accommodations, please visit our Visiting Us page.

Virtual Participation: The virtual portion of this program will be delivered via Zoom. Access instructions and login details will be provided to registered virtual attendees prior to the event.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 14 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements  

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 14 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program

  • 14 CME and Self-Assessment requirements of the American Board of Surgery’s (ABS) Continuous Certification (CC) program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation. MOC/CC points earned will be reported to the board within 45 days of completing the post-course evaluation.

ANCC CNE contact hours and Category 1 CEUs for Genetic Counselors pending.